ENTPD1 and head and neck cancer: However, recent studies in colon, ovarian, lung, endometrial, and head and neck cancers have linked a subset of clonally expanded, tumor-reactive T cells with the coexpression of CD39 and CD103 (26, 27, 41, 42).